Dr Lal seals Rp6.4bn Indian IPO at top end
Dr Lal Pathlabs has priced its Rp6.4bn ($95.2m) IPO at the upper end of guidance following strong demand from investors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: